Ann: Quarterly update and Appendix 4C, page-21

Something is going on, might not be too good, I suspect. They have consistently reported on the last Tuesday of July in the last 3 years. But this year they haven't done it. There are only 2 days left in July for them to report.

My greatest concern is their cash position. If they keep burning cash like before while FDA is stalled, they will be in trouble very quickly. The company's commercial execution of has been extremely disappointing. The pandemic gave them a once-in-a-lifetime opportunity, the company managed only to make a small kitty out of it. But the FDA progress was delayed and now stalled. With cash burn so high, they are in a worse position than they were before the pandemic. It is becoming hard to find an excuse.

Having been a very strong supporter for many years, my patience is running very thin indeed.